Cargando…
A bacterial cell factory converting glucose into scyllo-inositol, a therapeutic agent for Alzheimer’s disease
A rare stereoisomer of inositol, scyllo-inositol, is a therapeutic agent that has shown potential efficacy in preventing Alzheimer’s disease. Mycobacterium tuberculosis ino1 encoding myo-inositol-1-phosphate (MI1P) synthase (MI1PS) was introduced into Bacillus subtilis to convert glucose-6-phosphate...
Autores principales: | Michon, Christophe, Kang, Choong-Min, Karpenko, Sophia, Tanaka, Kosei, Ishikawa, Shu, Yoshida, Ken-ichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052218/ https://www.ncbi.nlm.nih.gov/pubmed/32123276 http://dx.doi.org/10.1038/s42003-020-0814-7 |
Ejemplares similares
-
An improved Bacillus subtilis cell factory for producing scyllo-inositol, a promising therapeutic agent for Alzheimer’s disease
por: Tanaka, Kosei, et al.
Publicado: (2013) -
A new-generation of Bacillus subtilis cell factory for further elevated scyllo-inositol production
por: Tanaka, Kosei, et al.
Publicado: (2017) -
A cell factory of Bacillus subtilis engineered for the simple bioconversion of myo-inositol to scyllo-inositol, a potential therapeutic agent for Alzheimer's disease
por: Yamaoka, Masaru, et al.
Publicado: (2011) -
Bacillus subtilis IolQ (DegA) is a transcriptional repressor of iolX encoding NAD(+)-dependent scyllo-inositol dehydrogenase
por: Kang, Dong-Min, et al.
Publicado: (2017) -
Antiepileptic Properties of Scyllo-Inositol on Pentylenetetrazol-Induced Seizures
por: Wiśniewski, Karol, et al.
Publicado: (2023)